CN Stock MarketDetailed Quotes

Hunan Er-kang Pharmaceutical (300267)

Watchlist
  • 4.48
  • +0.06+1.36%
Post Market May 20 15:00 CST
9.24BMarket Cap-23.46P/E (TTM)

Hunan Er-kang Pharmaceutical (300267) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Ingredients755.27M64.79%
New energy materials213.28M18.29%
Raw material medicine87.52M7.51%
Finished product medicine76.47M6.56%
Other33.22M2.85%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical industry919.26M78.86%
New energy industry213.28M18.29%
Other33.22M2.85%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Central China275.4M23.62%
South China261.94M22.47%
East China region223.34M19.16%
Overseas region167.18M14.34%
North China87.97M7.55%
Southwest area78.54M6.74%
Northeast area42.38M3.64%
Northwest region29.01M2.49%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 19, Eastern Time, Trump issued a clear countdown: 'in two or three days—maybe Friday, Saturday, Sunday, or early next week'—the U.S. Show More